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Abstract
The purpose of this study was to evaluate the use of semi-structured interviews as an outcome
measure in a clinical trial for children with fragile X syndrome (FXS). A qualitative approach
was used to analyze twenty-five parent interviews with children with FXS who participated in a
double-blind medication trial. Each participant received either sertraline or a placebo. The aim of
this research was to assess differences in occupational functioning in the sertraline group and
placebo group, that may not have been detected with the use quantitative outcome measures
alone. Results showed greater improvements in the sertraline group in areas of behavior, social
participation, sensory-related behaviors, receptive language, education and family impact. The
study’s findings support the use of semi-structured interviews as an additional outcome measure
in a medication trial. The qualitative methods add voice and context to the family experiences
through an occupation-centered lens.
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Living with Fragile X Syndrome: Occupations as an Outcome Measure in a Clinical Trial
Fragile X syndrome is the most common inherited cause of intellectual and
developmental disability (IDD) and is a single gene cause of autism spectrum disorder (ASD)
(Hess et al., 2016; Hessl et al., 2016; National Fragile X Foundation, 2017). This
neurodevelopmental disorder causes a wide range of symptoms including: intellectual disability,
increased anxiety, self-injurious behaviors, self-stimulatory behaviors, sensory processing
disruptions and behavioral excesses (Brady, Skinner, Roberts & Hennon, 2006; Hess et al., 2016;
Woodcock, Oliver & Humphreys, 2009). Many of the behavioral symptoms manifested by FXS
are managed with the use of therapeutic interventions and medications (Berry-Kravis, Sumis,
Hervey, & Mathur, 2012). The impact of medications can be significant in improving the
behavioral symptoms for both the child with FXS and the daily experiences of the family.
However, current medication trial research has predominantly used quantitative outcome
measures and standardized assessments to detect changes in functioning. Often, these assessment
tools do not reflect children’s improvements in everyday life (Berry-Kravis et al., 2012). The
addition of semi-structured interviews builds on traditional quantitative data methodology by
providing context in order to understand the effects of medications on daily life. The purpose of
the research was to examine outcome measures in the form of semi-structured interviews to gain
perspective of changes in functioning through an occupation centered lens.
Occupations are daily activities that people participate in to provide meaning and a sense
of purpose in their daily life (American Occupational Therapy Association [AOTA], 2014).
These occupations include activities and aspects of daily life that give a child, and his or her
family, a sense of independence, autonomy and well-being. For children, some important
occupations may relate to everyday self-care tasks such as feeding, dressing, playing, education
1
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and social participation. Children and their families living with FXS may often have difficulties
participating in even the most basic occupations. Basic tasks such as dressing, feeding, sleeping,
and social participation are often difficult for individuals with FXS. This can be due to
symptomatology including difficulties in behavior, sensory processing, emotional regulation and
communication.
This current study used data collected from a clinical medication trial conducted at the
U.C. Davis Medical Investigation of Neurodevelopmental Disorders (MIND) Institute. This
study examined semi-structured interviews of parents of children with FXS conducted at the
post-test concluding visit of a clinical trial. Families were asked to describe examples regarding
perceived changes in daily lived experiences and occupations. The use of semi-structured
interviews provided an additional way to detect functional changes in response to the medication.
Finding effective medications can be helpful for a child when receiving additional therapy
services, such as occupational therapy, by providing the child scaffolding and assistance to
improve functioning. Additionally, it is important to understand how children and their families
benefit from medications in order to provide occupational therapy treatments that are clientcentered.

2
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Literature Review
Introduction
Fragile X syndrome is a genetic condition that causes a range of developmental
impairments including cognitive deficits and learning disabilities (Smith, Hong, Greenberg &
Mailick, 2016). Approximately 60% of males and 14% of females with FXS are also diagnosed
with ASD (Thurman, McDuffie, Kover, Hagerman & Abbeduto, 2015). Additionally, 10% of
individuals with ASD have FXS as a comorbid condition (National Fragile X Foundation, 2017).
Males tend to be more affected than females because FXS is caused by a mutation on the X
chromosome. Approximately 1 in 4,000 males and 1 in 6,000 females across all ethnic groups
are diagnosed with FXS (Brady et al., 2006; Hess et al., 2016; Kurtz, Chin, Robinson, O’Connor
& Hagopian, 2015).
FXS is caused by a mutation on the fragile X mental retardation (FMR1) gene, which
leads to an expansion of the DNA segment CGG triplet repeat (National Institute of Health
(NIH), 2016). In typically developing individuals, this DNA segment repeats about 5-40 times.
However, the DNA sequence in individuals with full mutation FXS repeats over 200 times. This
abnormality results in a lack of production of the fragile x mental retardation protein (FMRP),
which affects nervous system functioning and results in the genotype and phenotype of FXS
(NIH, 2016). The FXS phenotype includes long face, large ears, soft skin, hypotonia,
hyperextensible joints and enlarged testicles. Some of these features, such as the long face and
large testicles, become more prominent during puberty (National Fragile X Foundation, 2017).

3
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Phenotypes
The following phenotypes are common in individuals with FXS and include impaired
cognition, difficulties processing sensory information, impaired communication, behavioral
excesses, high levels of anxiety and sleep disturbances. The manifestations of these phenotypes
present differently in each child. Some children may have limited symptoms, while others may
have severe intellectual disabilities (Cleveland Clinic, 2016). Despite the range of symptoms,
these phenotypes have a great impact on both the child and their family.
Cognitive. Males experience a higher degree of severity in symptoms when compared to
females with FXS. Males often exhibit mild to moderate intellectual and developmental
disability (IDD), while only 33% of females exhibit IDD (Brady et al., 2006; National Fragile X
Foundation, 2017). Males, more often than females, display overall global delays including
executive functioning, language, sensory processing deficits and communication delays (Brady
et al., 2006). Frolli, Piscopo & Conson (2014) discovered that a lack of attentional control is a
main reason for global delays involving deficits in problem solving, working memory, and
language processing. The lack of attentional control further increases the expression of
behavioral symptoms such as inattention, hyperactivity, and attention deficit disorder. These
symptoms are seen in 90% of males with FXS and greatly impact occupational performance
(Frolli et al., 2014; Hagerman et al., 2009; Oakes et al., 2016; Thurman et al., 2015).
Sensory. Individuals with FXS have problems with sensory processing and difficulty
integrating various types of sensory stimuli (Hagerman et al., 2009). Individuals with FXS have
been found to have an enhanced electrodermal response (EDR) to stimuli when compared to
typically developing children (Hagerman et al., 2002). Increased EDR responses among children
with FXS are correlated with unusual reactions to sensory stimuli, along with symptoms of
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hyperactivity and associated behavioral problems (Miller et al., 1999).
Sensory processing deficits can ultimately impair overall functioning and occupational
performance (Baranek et al., 2002). Children with FXS often avoid tactile and visual input,
which results in decreased occupational performance in self-care, school performance, and play
activities (Baranek et al., 2002). Furthermore, children with FXS have difficulty shifting
attention and modulating responses to auditory input (Van der Molen et al., 2012). Overall,
difficulties with modulation of sensory input and other sensory processing deficits impact
important occupations in a child’s daily life by limiting functioning in areas such as school and
classroom participation, along with everyday tasks like feeding or dressing (Van der Molen et
al., 2012).
Anxiety. Approximately 75% of individuals with FXS are diagnosed with a comorbid
condition of anxiety (Tonnsen, Malone, Hatton & Roberts, 2013). Anxiety is often experienced
particularly after unexpected changes in routines and social situations (Woodcock et al., 2009).
Woodcock et al. (2009) described how children with FXS were rigid towards these types of
changes and the anxiety is a result of these unwanted changes. Parents reported behaviors
associated with anxiety which included sleeping problems, distractibility, and increased arguing.
Furthermore, anxiety may increase symptoms of hand-flapping or social avoidance (Tonnsen et
al., 2013).
Communication. Children with FXS often experience delays in communication
development (Brady et al., 2006). It is possible that certain behaviors associated with FXS affect
a child’s delay in communication (McDuffie et al., 2016). These behaviors may include
inattention, repetitive behaviors and restricted interests that may prevent active exploration of the
environment and interfere with meaningful participation in daily routines that support language
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learning. Additionally, Abbeduto et al. (2003) reported delays in many areas of language and
speech, particularly expressive and receptive language in males with FXS. Although receptive
language usually develops quicker than expressive language in children with FXS, it is still
markedly delayed compared to typically developing children (Hahn, Zimmer, Brady, Swinburne
Romine & Fleming, 2013). Furthermore, IDD is a contributing factor to the development of
language. The limitation in intellectual functioning delays the ability to learn language and
communication (American Speech-Learning-Hearing Association, 2017). According to a study
conducted by Roberts, Hatton and Bailey (2001), the average age for males with FXS to speak
their first word was 28 months which is substantially below developmental norms. Parent reports
suggested that although speech was often significantly delayed, most children eventually learned
to speak (Brady et al., 2006). Furthermore, males with FXS more commonly stay nonverbal than
females (Abbeduto, Brady & Kover, 2007).
Behavioral excesses. Self-injurious behaviors (SIB), most commonly self-hitting and
self-biting, occurs in at least 50% of males with FXS (Hessl et al., 2008). SIB and repetitive
behaviors often begin as early as 12-15 months of age (Hessl et al., 2008). It is believed that
children who present with high levels of repetitive behaviors also engage in higher rates of SIB
(Richards, Oliver, Nelson & Moss, 2012). In addition, Oakes et al. (2016) reported SIB becomes
more problematic with age, starting in adolescence and continuing into young adulthood.
Similarly, aggressive behaviors, including hitting, biting, and yelling, have also been reported as
a concern for this population (Wheeler, Raspa, Bishop & Bailey, 2016). Furthermore, Wheeler et
al. (2016) discovered that 90% of the participants with FXS engaged in aggressive behaviors and
30% caused harm to their caregivers.
Sleep. Children with IDD generally face more sleeping problems than the general
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population (Kronk et al., 2010) and this is true for FXS. In a study conducted by Richdale
(2003), approximately 77% of children with FXS experience sleeping problems. These sleeping
problems included frequent night waking, co-sleeping, excessive daytime sleepiness, settling
difficulties, bedwetting and sleep talking. High occurrences of sleeping problems are common in
children with FXS because of the high levels of anxiety and psychopathology (Richdale, 2003).
Current research suggests that approximately 50% of children with FXS take medication for
sleep problems (Kronk et al., 2010). These sleep patterns often affect daily occupations for
children due to the lack of sleep and fatigue. Poor sleep hygiene, along with the many behavioral
symptoms associated with FXS often impact the family dynamic and their day to day
occupations.
Family Impact
Raising a child with a disability is challenging for families with children with FXS,
particularly for mothers who assume the role of primary caregiver (Wei & Yu, 2012). Primary
caregivers have been found to struggle with physical and mental health problems such as
depression and anxiety (Rie et al., 2016; Baker, Selzer & Greenberg, 2012). Research has shown
that families experience difficulties in areas such as mental and physical health, daily activities,
financial status and employment (Baker et al., 2012; Ouyang, Grosse, Raspa & Bailey, 2010;
Reilly, Murtagh & Senior, 2015). Recent studies have used quantitative methods such as surveys,
checklists and scaled assessments to gather sensitive family information. These quantitative
outcome measures fail to capture the voice, context and occupations of the families lived
experiences. By using qualitative methods such as parent interviews, parents can share valuable
and in-depth information about their daily occupations.
Finances and employment. Families who have a child with FXS often experience a high
7
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level of financial burden when providing care for their child (Ouyang et al., 2014). In a study
conducted by Ouyang et al. (2014), researchers examined the financial impact on FXS families
when compared to families with other disabilities. Researchers used a battery of parent
questionnaires and assessment methods. Results indicated that FXS families experienced higher
levels of financial and employment burden when compared to families living with other
intellectual disabilities (Ouyang et al., 2014).
Although most families with a child with FXS had insurance coverage, they reported
having inadequate coverage to cover all services needed. Parents were financially responsible for
an average of $17,476 (USD) out of pocket expenditures, or approximately 5% of their family's
income (Ouyang et al., 2010). Families who had lower incomes, often felt more financial burden
than did families who had larger incomes. These out of pocket expenditures were often used for
therapeutic interventions, medication, transportation, supervision, genetic testing and other
medical needs for their child (Ouyang et al., 2010).
Families also experienced work disruptions related to taking care of a child with FXS.
Parental surveys on employment status found that families raising a child with FXS had
difficulties with full time employment (Rei et al., 2016). Parents were frequently forced to quit,
turn down jobs, or change work hours in order to take care of their child (Ouyang et al., 2010).
Families with multiple children with FXS, often experienced larger financial burden and had
even more difficulty maintaining full time employment than families with one child with FXS
(Ouyang et al., 2010). Although this study informs the FXS community about valuable statistics
of parental employment disruptions and economic hardship, it fails to capture a rich detailed
picture of the difficult experiences of the families. Including qualitative methods such as parentinterviews, can provide additional information on the families’ lived experiences.

8
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Parent restrictions and concerns. Children with FXS have various behavioral problems
that make it challenging for families to complete daily activities (Reilly et al., 2015). Through
the use of quantitative checklists, Reilly et al. (2015) found that families often had difficulties
with feeding, maintaining sleep schedules and managing destructive behaviors of their children
with FXS. Parents reported that they felt restricted in their ability to go shopping, use public
transportation and take family vacations with their child (Reilly et al., 2015). Additionally,
parents were concerned about their child’s future, along with their ability to live independently
and have gainful employment (Reilly et al., 2015).
Future care of an individual with FXS is often placed on the child’s siblings, when the
parents are no longer able to take care of the individual (Rie et al., 2016). Siblings often noted
that taking care of their brother or sister with FXS was difficult, and they needed to find a
flexible job that allowed them to take care of their sibling (Rie et al., 2016). Findings from these
quantitative studies provide an important initial understanding of the impact of FXS on daily life
of families.
Behaviors and resiliency. Mothers of children with FXS report high levels of depression
and anxiety due to the behavioral phenotypes related to the disability of their child (Baker et al.,
2012). Researchers used parental checklists and mental health scales assessing anxiety,
depression, marital satisfaction and family cohesion. Researchers found that behavioral
interventions were shown to improve symptoms of children with FXS as well as improve mental
health of parents and caregivers (Baker et al., 2012). Additionally, research conducted by Weber
(2016) evaluated a single subject case study of a mother through the means of interviews and
observations. The research found that the mother of a child with FXS developed resilient
strategies to cope with the high levels of depression, anxiety, and stress (Weber, 2016). The
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mother used her internal resources, family and community support systems, religious beliefs, and
role models to develop coping strategies. These strategies helped her manage stress and the
difficulties faced when caring for a child with FXS (Weber, 2016). Because this research
utilized qualitative methodology, valuable information was gained about the daily lived
experiences of life with FXS.
In order to address the challenges of living with FXS, many families pursue a variety of
interventions including therapies and medications to improve behavioral symptoms and overall
daily functioning (Berry-Kravis et al., 2012; Fernández Carvajal & Aldridge, 2011).
Interventions
Therapeutic interventions. Due to the increase in the knowledge of the genetics of FXS,
there have been many developments in the types of interventions, which are used to treat
children with FXS (Fernández Carvajal & Aldridge, 2011). Children with FXS usually partake in
a variety of therapeutic interventions, which include psychological services, special education,
occupational therapy, behavioral therapy, physical therapy, and speech and language pathology
services (Fernández Carvajal & Aldridge, 2011; National Fragile X Foundation, 2017). In
addition to these therapeutic interventions, medication is often prescribed to treat behavioral
symptoms. The medication aims to place children at an optimal level of functioning by
alleviating symptoms to better respond to therapy services (Fernández Carvajal & Aldridge,
2011).
Medication management. Current research indicates 77% of all children with FXS take
medications to manage behavioral symptoms (Berry-Kravis et al., 2012). Common classes of
medications that are prescribed to children with FXS include stimulants, antipsychotics, alpha-2agonists, antibiotics and antidepressants. A retrospective study conducted at Rush University
10
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Medical Center Fragile X Clinic found that 73% of the patients who took medication responded
positively towards at least one type of treatment (Berry-Kravis et al., 2012).
Selective serotonin reuptake inhibitors (SSRIs) are a type of antidepressant that has been
approved by the U.S Food and Drug Administration to treat symptoms related to obsessive
compulsive disorder, anxiety, and depression in children with FXS, ages 5 and over (BerryKravis et al., 2012; Hagerman et al., 2009; Mayo Clinic, 2016). SSRIs work by blocking the
reuptake of the neurotransmitter, serotonin, thus increasing the levels of serotonin in the brain
(Selective serotonin reuptake inhibitors, 2016). Serotonin aids in creating essential neural
pathways in the brain during early development that extend into adulthood (Wirth, Holst &
Ponimaskin, 2016). Previous research has shown that children with ASD, a closely related
disorder to FXS, have lower levels of serotonin when compared to neurotypical children
(Winarni et al., 2012). Administering medications such as SSRIs to children in the first 5 years
of life may be beneficial due to the rapid of synapse formations and development (Hess et al.,
2016). Furthermore, lab mice with FXS have dysregulated neural pathways in the hippocampus
region of the brain (Costa, Sardone, Lacivita, Leopoldo, & Ciranna, 2015). The hippocampal
region of the brain is thought to play an essential role in the regulation of emotions. Differing
neural pathways in the hippocampus could possibly be the cause of emotional dysregulation,
which is often found in children with FXS.
Sertraline (trade name Zoloft®), a common SSRI, has been used clinically to treat
anxiety, irritability, and socialization problems for children with FXS (Hess et al., 2016; Winarni
et al., 2012). This medication has been highly beneficial in improving speech and decreasing
levels of anxiety with children with FXS (Winarni et al., 2012). A randomized control trial found
that low doses of sertraline, significantly improved social participation, expressive and receptive
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language, visual tracking and fine motor skills compared to placebo in young children with FXS
(Hess et al., 2016). Sertraline has been found to be effective as a treatment for children with FXS
2-6 years old with minimal side effects. Side effects may include drowsiness, dizziness, nausea,
insomnia, dry mouth, diarrhea and others (Hess et al., 2016; U.S. Food and Drug Administration,
2014).
On the other hand, family members may find it difficult to give their children
pharmaceutical drugs at a young age. Research regarding parental attitudes towards medication
found that parents were more likely to have their children adhere to medication timelines if they
believed their children’s behaviors improved (Nagae, Nakane, Honda, Ozawa & Hanada, 2015).
In addition, parents were more likely to have their children take medication if they were educated
by the physician about the medication (Nagae et al., 2015). Therefore, it is essential for the
family members to be informed about the potential risks and benefits when taking medications.
In recent years, research on the genetic and neurobiological factors of FXS have
advanced due to several important studies involving animal models and placebo-controlled
randomized trials (Berry-Kravis et al., 2013; Hess et al., 2016; Hessl et al., 2016). Enhanced
understanding of the underlying molecular mechanisms of FXS has led to an increase in the
clinical use of medications to treat behavioral and cognitive symptoms (Hall, Hammond, Hirt, &
Reiss, 2012; Hessl et al., 2016). Research studies on pharmacologically-based treatment methods
have provided promising and valuable information about potential future treatments of FXS
(Berry-Kravis et al., 2013; Hessl et al., 2016). In previous targeted medication treatment trials,
many of the outcome measures have been quantitative, standardized, developmental measures.
These measures have provided valuable results regarding the efficacy of different medications as
a targeted treatment for symptoms of FXS (Berry-Kravis et al., 2013; Hessl et al., 2016).

12
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However, certain factors related to these outcome measures and characteristics of the FXS
population have made it difficult to assess improvements in daily occupational functioning and
independence (Baranek et al., 2002; Berry-Kravis et al., 2013; Hess et al., 2016; Hessl et al.,
2016).
Difficulty Measuring Outcomes in Individuals with FXS
The following section will examine limitations with current outcome measures in
research with individuals with FXS. First, difficulties with using current standardized
assessments among participants with FXS will be addressed. Next, this section will examine the
results of a previous FXS medication trial conducted at U.C. Davis MIND Institute. Lastly, the
section will examine the benefits of caregiver/parent interviews as an additional occupational
outcome measures when examining improvements of children in a clinical mediation trial.
Previous research on the FXS population has provided important and significant results
regarding successful medications and treatments for various behavioral and cognitive symptoms
of FXS. However, there are certain problems associated with the use of quantitative standardized
assessments during research, which makes measuring functional improvements difficult. Current
research on family impacts are mostly quantitative research studies with a small amount being
mixed method or qualitative in nature.
Floor effects and effect sizes. Standardized assessments are commonly used as a
primary outcome measure in pharmacological treatment studies (Hall et al., 2012). However,
these assessments often lack sensitivity to change over time when measuring changes in daily
life functioning for children with FXS, ASD and IDD. According to Hall and colleagues (2012),
many standardized tests have poor psychometric properties when measuring changes in the
fragile X population. This results in floor effects and small effect sizes (Hall et al., 2012). Floor
13
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effects occur when standardized tests are too difficult for the treatment population. The majority
of participants receives scores that fall within the 1st and 2nd percentiles and never rises above
the normative floor (Berry-Kravis et al., 2013; Hall et al., 2012; Hess et al., 2016). Effect sizes
are another problem resulting from difficulty measuring outcomes in the current body of research
on FXS, and this has impacted the ability to determine treatment effects in previous studies
(Berry-Kravis et al., 2013; Hess et al., 2016; Hessl et al., 2016). Effect size is a measure of the
differences in effect of the independent variable on the dependent variable, which allows for the
comparison between groups. These limitations raise the risk that meaningful interventions may
be overlooked (Berry-Kravis et al., 2013; Hall et al., 2012). As an alternative to traditional
outcome measurements, a recent study evaluated a learning platform to measure learning rates
among participants with FXS (Hall et al., 2012). To prevent influences on performance and to
encourage responses in participants, researchers implemented a computerized test. This learning
platform used automated reinforcement, feedback, token delivery, and prompting procedures.
This approach led to decreased floor effects, and all of the participants with FXS were able to
complete the test (Hall et al., 2012). Additionally, when considering floor effects among children
with FXS, it is also important to examine the impact of behavioral symptoms on overall
occupational performance during standardized assessments.
Behavioral, language and visual issues in outcome measures. Individuals with FXS
often have different behavioral presentations of symptoms and experience problems processing
verbal or visual cues. The use of verbal instructions in standardized assessments may be
problematic for many individuals with FXS who have language processing deficits (Hall et al.,
2012). Maladaptive behaviors can impede performance on standardized measures (Berry-Kravis
et al., 2012; Hall et al., 2012). Hall and colleagues (2012) explained that common assessments

14
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used in clinical trials are not ideal for the FXS population due to a lack of reinforcement and the
use of face-to-face interactions during testing administration. Taken together, floor effects and
behavioral disruptions limit the utility of assessments currently used during clinical medication
trials involving children with FXS. The addition of qualitative methods and interviews can lend
an additional, contextually based functional measure to better understand the occupational
changes of individuals with FXS in clinical medication trials.
Additional approaches. The use of qualitative methods, such as semi-structured
interviews, is one additional approach to standardized assessments. Qualitative measures provide
context and additional information about the impact of behaviors on children with FXS and their
families. The use of qualitative outcome measures in clinical medication trials would provide an
additional method to detect behavioral improvements and occupational performance in children
with FXS (Baranek et al., 2002; Berry-Kravis et al., 2012). In a study conducted by Baranek et
al. (2002), researchers examined the sensory processing and occupational performance of 15
school-aged boys with full mutation FXS. Results were obtained through a comprehensive,
multi-modal assessment process, which included one Likert scale parent-report measure and two
observational measures. The researchers explained that this approach of a varied battery of
outcome measurements was more sensitive to individual variations in sensory processing among
children with FXS (Baranek et al., 2002). However, the research failed to include a qualitative
component, which would have provided an additional method of capturing improvements in
daily occupational performance.
Benefits of using parent/caregiver-reports and interviews. Several previous studies
examining clinical interventions for FXS have used standardized parent/caregiver-reports, such
as the Sensory Processing Measure-Preschool (SPM-P) and the Aberrant Behavior Checklist, as
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a way to determine impacts on overall functioning (Berry-Kravis et al., 2013; Hess et al., 2016;
Knoth et al., 2014). However, the use of parent or caregiver interviews has not occurred in the
majority of studies on FXS. Although these quantitative measures provide information regarding
home and school functioning, they fail to capture a rich understanding of the daily lived
experience and occupational changes in children with FXS and their families as the responses are
limited to the likert scale per each individual question. The addition of qualitative semistructured parent interviews would provide a more comprehensive insight into the children’s
daily functioning and overall occupational performance.
Due to problems using standardized measures of behaviors in clinical treatment trials,
interviews focusing on the impact of living with FXS on family members and caregivers would
be informative. According to Hagerman et al. (2009), research studies in the past have shown
that the challenging behaviors of individuals with FXS have “the greatest impact on parents and
families, greater than that of cognitive impairments” (p. 384). The importance of family
perceptions was also highlighted in a study evaluating the effects of sertraline on language
development (Hess et al., 2016). The authors noted that when considering improvements in
social participation, some families indicated improvements in daily routines: being able to play
with others, participating in family meals and outings in the community (Hess et al., 2016). The
results of parental checklists demonstrate the benefits of familial insights. However, these
quantitative methods are limited in their capacity to fully capture a rich understanding of the
family experience. Adding qualitative methods which delve deeper into daily improvements,
may display improvements in occupational functioning which may not be captured by the
parental questionnaires.
Outcome measures should adequately cover the type and severity of problems most
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detrimental to the individual’s daily functioning and overall quality of life (Berry-Kravis et al.,
2013; Hessl et al., 2016). It would be beneficial to further understand the experiences of family
members that care for individuals with FXS on a daily basis. Qualitative outcome measures in
the form of semi-structured parent/caregiver interviews may allow for a rich understanding of the
impact of FXS on a child and their family.
Previous Research
This qualitative research is a secondary analysis of data collected from a study conducted
at the U.C. Davis MIND institute by Hess and colleagues (2016). This randomized double-blind
placebo control trial, examined the effects of low dose sertraline on children aged 2-6 with full
mutation FXS. A total of 52 children participated in the study and were randomized into either
the sertraline treatment group or a placebo group for 6 months. Parents of the participants were
blind to whether their child was given sertraline or the placebo and unblinded at the 6-month post
intervention. A battery of pre and post tests were administered in the clinic at baseline and at the
6 month follow up visit which included the Mullen Scales of Early Learning (MSEL), The
Preschool Language Scale (PLS), Sensory Processing Measure-Preschool (SPM-P), Visual
Analog Scale, and Autism Diagnostic Observation Schedule®-2 (ADOS-2). The Clinical Global
Impression Scale (CGI-I) was also used, however this scale was only conducted at the 6-month
post-test. Semi-structured parent interviews were also conducted at baseline and again at 6month post testing in order to determine the family perceptions of improvements in behavior and
changes in daily occupational functioning. These interviews were conducted by a licensed
occupational therapist (Hess et al., 2016). The interviewer was blind to group assignment for the
duration of the randomized double-blind placebo control trial.
According to the study conducted by Hess et al. (2016), significant improvements were
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found in the sertraline group in visual/motor perceptual subsets, expressive/receptive language
and visual tracking on the MSEL assessment. Other significant improvements in the sertraline
group were found in fine motor skill portion of the MSEL, and social participation on SPM-P.
Researchers found that parents reported improvements in social participation in school
and home performance on the SPM-Preschool Home Form. However, the researchers stated that
the use of quantitative reports may have contributed to limitations including missing data
sensitivity and floor effects among the sertraline and placebo groups (Hess et al., 2016). In order
to build on this important research and to address some of these limitations, we used a qualitative
approach in order to gain a deeper understanding of the daily lived experiences and behavioral
changes of children with FXS during the medication trial.
Purpose Statement
The impact of medication can be significant in improving the symptoms associated with
the behavioral phenotype of FXS (National Fragile X Foundation, 2017). The improvements in
behavior can be important in enhancing daily occupations for both the child with FXS and his or
her family. Current research has predominantly utilized a medical model and quantitative
assessments. Results from these studies have provided valuable information, however these
studies have been limited in their ability to detect improvements in everyday life among
participants with FXS. The purpose of the study was to examine the additional outcome measure
of semi-structured interviews which are occupation centered. The main research objectives were
to (1) examine if semi-structured parent interviews can be used to ascertain if differences can be
detected with qualitative interview data and (2) examine the difference in behavioral outcomes
between the sertraline and placebo groups when studying children with FXS in a clinical trial.
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Theoretical Framework
Vygotsky’s sociocultural theory was used to guide the research study. The social
experiences in an individual’s everyday life are essential to the learning process. According to
this theory, social interaction is a fundamental aspect of learning and the development of
cognition (Vygotsky, 1930). Vygotsky noted that a child’s development is a process that goes
beyond biology. He asserted that the physical and social environmental interactions a child has
are also essential to development of behaviors and learning (Vygotsky, 1930). Learning is
viewed as a process that occurs on two different levels: one level occurs when the person
interacts with others and the second level takes place when this learning is integrated into that
individual’s mental structure (Vygotsky, 1930). This means that learning occurs at both a social
and individual level. When considering treatment for maladaptive behaviors in children with
FXS, the social interaction of the family, community members and service providers are
important to the child’s individual development.
The “zone of proximal development” is another key aspect of Vygotsky’s sociocultural
theory. This is an area of exploration in which an individual’s capacity for cognitive
development is enhanced (Vygotsky, 1930). In the “zone,” a child is in a place where they have
the ability to explore and learn, but need outside reinforcement, scaffolding and social support to
do so (Vygotsky, 1930). For a child with FXS, this reinforcement and social support comes from
family members, teachers and therapists. When a child with FXS receives sertraline as part of
treatment they may be put into a better “zone” for learning, along with a better chance of having
positive social interactions with family and occupational therapists. These interactions ultimately
improve the child’s ability to learn and improve behaviors that negatively impact daily life.
For example, in Hess et al. (2016), children with FXS taking sertraline demonstrated
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improvements in receptive language. Arguably, the medication could put a child in a better
“zone” so the child can learn more in a school setting while having positive interactions with
peers. In the proposed study, analysis of parent interviews during a clinical trial of sertraline will
provide context and an in-depth understanding of the social components that ultimately impact
learning and improvement of occupational outcomes in children with FXS.
In addition to sociocultural theory, the Occupational Therapy Practice Framework:
Domain and Process, 3rd edition (OTPF) was also used to guide this research study and inform
definitions and descriptors for all code categories included for data analysis. The OTPF is an
official framework of the American Occupational Therapy Association that is used to guide
occupational therapy practitioners and students by outlining the most important concepts related
to the practice and the vision of OT (AOTA, 2014). The OTPF was used in the current study to
identify and describe important occupations of a child with FXS. By defining important
occupations, such as education or social participation, the researchers were able to ensure
accurate analysis of overall daily functioning and occupational performance.
Ethical and Legal Consideration
The AOTA Code of Ethics was used throughout the proposed study to maintain
autonomy and confidentiality, along with veracity of participants (AOTA, 2015). Autonomy was
upheld in this study by maintaining confidentiality of participants and their family members
(AOTA, 2015). Methods to ensure confidentiality included securing audio interview data
containing sensitive participant information. Each participant was assigned a numerical code and
the master list was kept in a secure file in a locked office on a password protected desktop
computer to ensure that the names are kept confidential. Interview transcriptions were
anonymous. All identifying information was removed and participant’s names were written as
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BOYXXX or GIRLXXX. Research assistants were used to assist in transcribing the interviews
and signed a confidentiality agreement (Appendix A).
Additionally, researchers upheld veracity by accurately transcribing and coding the data
(AOTA, 2015). Researchers were truthful and fair with the results of the study. This was an
important aspect of the research since the results were generated solely from researcher coding.
The study was based on a previous research conducted by Hess et al. (2016). Data was
obtained with permission from an existing database at the U.C. Davis MIND Institute. Attached
in Appendix B is the letter of approval to use the data from the previous study’s principal
investigator, Dr. Randi Hagerman, MD. The research study was accepted by the Dominican
University of California Institutional Review Board (IRB) for the Protection of Human Subjects
(IRB#10528). This process ensured that the research did not breach confidentiality of the
participants involved in the study. All participants names used were assigned pseudonyms to
ensure confidentiality when discussing content. The original study was funded by Health
Resources and Services Administration Grant HRSA (#R40MC22641).
Definitions and Variables
Parental interview questions are included in Appendix C. Codes and operational
definitions are included in Appendix D.
Methodology
This study examined occupational improvements in children with FXS who participated
in a clinical medication trial with the use of semi-structured parent interviews. The original
research conducted at the U.C. Davis MIND Institute showed statistically significant
improvements in functioning in social participation, expressive and receptive language, visual
tracking and fine motor skills in children with FXS (Hess et al., 2016). However, floor effects
21

LIVING WITH FXS: OCCUPATIONS AS OUTCOME MEASURE

and outcome measure limitations in the FXS population may have limited the scope and depth of
improvements demonstrated by children and the impact on family life. The objective of the
current research was to (1) examine if semi-structured parent interviews can detect differences in
improved daily function between placebo and treatment groups when studying children with
FXS in a clinical trial and (2) examine the difference in behavioral outcomes between the two
groups.
Design
The study utilized a qualitative design to analyze semi-structured parent interviews in
order to explore family perceptions of improvements in the participant's’ daily functioning and
provide context to determine a difference in behavioral outcomes between a group of children
taking sertraline or a placebo for six months. This method was selected to assess any changes in
the day-to-day life of participants. These interviews were transcribed and coded to identify
commonalities among the responses of the families. This method is ideal to gain insight on the
lived experience of families through an occupation-centered lens.
Population
The population for the original research at the MIND Institute at U.C. Davis was children
2-6 years old with the full mutation of FXS (Hess et al., 2016). There were a total of 52 children
who participated in the study. The inclusion criteria required that the children are between 2 to 6
years of age and English speaking. Children with FXS were included in the study regardless if
they were diagnosed with ASD or not. Exclusion criteria included any other central nervous
system disease. Additionally, the children’s parents were involved in a semi-structured interview
to gather data regarding their daily lived experiences of the child with FXS (Hess et al., 2016).
This current study was conducted using secondary analysis of data and participant
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information based on a subsample of 25 semi-structured parent interviews originally collected
during a medication trial at the U.C Davis MIND Institute (Hess et al., 2016). There were 12
participants in the sertraline group and 13 in the placebo. When looking at demographics across
the two groups, a total of 20 males and 5 females were included. In the sertraline group there
were 8 males and 4 females. In the placebo, 12 males and 1 female made up the total number of
participants.
Data Collection
The semi-structured parent interviews from the original U.C. Davis MIND study (Hess et
al., 2016) included questions created to collect relevant information about the impact on family
occupations, along with perceptions of changes in participants’ levels of communication,
anxiety, behaviors, social participation, play, sleep, ADL functioning, education, and sensory
processing abilities.
In order to carry out data analysis of interview responses for the current study, all of the
interviews were transcribed verbatim and were completed by the primary research team and
research assistants. Research assistants signed a confidentiality agreement and followed
confidentiality security measures. Audio files were held on anonymized flash drives that were
kept in a locked cabinet in a locked office. The files could only be obtained via a formal check
out procedure. The files were only signed in and out by those on the research team. Audio files
were not allowed to be taken off the premises.
Data Analysis and Coding
Coding was completed through the use of Dedoose Software Version 7.1 (Dedoose,
2016). The data was coded and analyzed using the constant comparison method (Corbin and
Strauss, 1990). After the research assistants transcribed all audio recorded interviews, each
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primary researcher read each transcription while listening to the audio recording to confirm the
accuracy of the transcription (Dye, Schatz, Rosenberg & Coleman, 2000).
The open coding analysis began by breaking down the interviews into raw data bits.
These raw data bits were passages and excerpts from the parent based interview transcripts.
Excerpts were compared to each other in order to develop primary categories (Dye et al., 2000;
Saldana, 2009). These primary categories were informed by previous FXS literature, the OTPF,
and sociocultural learning theory. They were created using classification reasoning with intuition
to decide how raw data points “looked” or “felt” alike (Saldana, 2009). After creating primary
categories, inclusion criteria and operational definitions for the categories were made (Dye et al.,
2000). This creation of categories and definitions was completed with 100% consensus of the
team of four primary researchers. Additional codebook categories and operational definitions
were created throughout the coding process as part of the iterative process and again, all codes
were agreed upon 100% by the four research team members. Interviews were then back-coded to
ensure that all data points were covered. Researchers were blinded to the treatment condition
during the coding process and unblinded during analysis between sertraline and placebo groups.
Each primary researcher coded a total of 6 complete interviews. Data was placed into
categories based on the operational definitions. Categories included, anxiety, behavior,
communication, receptive language, expressive language, education, family impact,
functional/ADL, play, sensory, social participation, and family strategies. Each of these
categories was further analyzed into categories of improved, no change or worsened with the
exception of family impact which was described as either negative or positive. The raw data bits
that were not assigned to designated categories were placed into a miscellaneous/question
category and this data was comprehensively reviewed via consensus by the research team.
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Specific and memorable data points were assigned to a quotes category. This data process was
repeated with all 25 transcribed interviews (Dye et al., 2000).
Strategies for Trustworthiness and Bias Control
In order to ensure trustworthiness, the data was continuously reviewed throughout the
research study. Three full transcriptions were coded to 100% consensus by primary researchers.
An additional 17 of the remaining 22 interviews (77%) were coded to 100% consensus by one
additional researcher to ensure for trustworthiness and for bias. A total of 62 question codes were
assigned. Question codes were then assigned to a category after 100% consensus of all primary
researchers. Team meetings were held weekly to review data and question codes. All researchers
were responsible for creating, updating, revising and maintenance of the data (Saldana, 2009).
Results
The objective of the current research was to (1) examine if semi-structured parent
interviews can detect differences in improved daily function between placebo and treatment
groups when studying children with FXS in a clinical trial and (2) examine the difference in
behavioral outcomes between the two groups. As a result of data analysis, two dominant themes
emerged indicating behavioral and occupational commonalities and differences between
sertraline and placebo groups. These themes include improvements in daily functioning and
therapeutic strategies. All results were based off coding and analysis of parent interview
responses that were transcribed and analyzed into the following categories, behavior, social
participation, receptive language, sensory-related behaviors, education, family impact, and
therapeutic strategies. Results were measured based on frequency of code occurrences or
instances. Pseudonyms were used to preserve the confidentially of the participants.
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Improvements in Daily Functioning
The first dominant theme that was found in the research was improvements in daily
functioning in the sertraline group. Results indicated improvements in behaviors, social
participation, receptive language, sensory, education and family impact (See Figure 1).
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Figure 1 Improvements in daily functioning in the areas of behavior, social participation, sensory-related
behaviors, receptive language, education and family impact. Greater frequency of reported instances in all
categories for the sertraline groups.

Behaviors improved, less maladaptive or unwanted behaviors. There was a higher
frequency of behavioral improvements reported by the families of children in the sertraline group
when compared to the placebo group. Features in the category included various unwanted
behaviors as reported by parents: tantrums, hitting self or others, biting, crying and screaming.
Eva, a mother of Tyler, who was randomized into the sertraline group stated, “His behavior has
improved in the sense that he used to throw a lot of tantrums. Whenever he got frustrated he
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would throw himself on the floor and scoot backwards and his head would hit the floor or the
wall.” This excerpt describes a child taking sertraline who demonstrated a noticeable decrease in
tantrums and self-harming behaviors that previously had disrupted the child and family’s daily
lives. Barbara, a mother in the sertraline group also described improvements in behavior that she
observed in her son, “He started with his cup and he would throw it and make noises. He throws
it when he gets mad now but he knows momma is going to make him go pick it up… Before he
would go get his cup [and] keep throwing it or come pull on you.” In this quote, Barbara is
describing improvement in her son’s unwanted behaviors, throwing his cup, and how he was able
to understand the cause-and-effect or consequences of his behaviors.
Social participation. Results indicated that there was a difference between groups for
social participation, with a higher frequency of reported improvements in socialization behaviors
among families in the sertraline group. The improvements were described by family members
based on observations of the child’s ability to engage and participate in community-based
activities or family outings without negative or disruptive behaviors and distress. Some examples
provided by parents in the sertraline group included the ability to go out for dinner, visit
museums, or try new things on the playground. Beth, a mother of child in the sertraline group
described improvements in her son’s ability to socialize with peers: “His interactions with his
peers are better. That was one of his goals. And his aid that goes to school with him said that
he'll initiate interactions with them, and try to communicate with them.” This quote demonstrates
improved social participation, as indicated by Beth’s reports that her son is better able to sustain
or initiate conversations with peers during the school day.
Receptive language. When analyzing categorical codes for communication, differences
were specifically found for improvements in receptive communication, with excerpts describing
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improved receptive communication skills being reported more frequently by families in the
sertraline group when compared to the placebo group. Parents with children in the sertraline
group described perceived increases in their child’s ability to understand verbal or visual
information provided in various environments. Many of these families also explained how this
enhanced understanding resulted in better social interactions and an increase in positive
behaviors demonstrated by their child in the home or school environment. When asked about her
son’s changes in receptive communication since beginning the medication trial, Lucy described
how her son improved, “He understands what we're saying better, he listens better. And he can
communicate better.” This quote illustrates how improved receptive communication skills were
observed as contributing to more positive behaviors when following or listening to verbal input
and directions, along with enhanced communication overall. Another parent, Alanna described
how despite subtle changes in expressive language skills, her son’s improvements in receptive
communication were notable to her and their family: “He’s doing so much, even if he’s not
communicating it by saying it [but rather] him understanding it.” This excerpt highlights how
subtle changes in communication were demonstrated to this parent by her son’s ability to
understand more, and that what may seem like a subtle improvement was something that she felt
was significant in terms of his communication development.
Sensory improved, less maladaptive behaviors or responses. Interviews of family
members were analyzed to determine trends of improvements related to sensory processing or
reactions to various sensory stimuli in daily life. The participants in the sertraline group had
more reports of improvements in less negative or maladaptive reactions or behaviors. An
example of this included less self-harming behavior (hitting, scratching) in the presence of new
or aversive sounds, textures or other sensory stimuli. Nicole, the mother of a child in the
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sertraline group stated, “Harry is much gentler now. He now understands when I tell him [no,
when pulling my hair]. He understands that he has to be gentle [when he is just playing.” Pulling
hair is an example of what results when a child has difficulty controlling behaviors during play
or social interactions due to sensory difficulties, which can limit self-regulation and processing.
Nicole’s reports of less behaviors like hair pulling indicates that taking sertraline is related to
improvements in sensory processing and associated behaviors.
Education. For the theme of education, family interviews were coded to determine any
positive behaviors or improvements related to school performance or in skills that are important
for a child’s success in educationally based activities. Examples of the descriptors for this code
category included increased participation in the classroom during group activities, teacher reports
to parents about improvements in behaviors during the school day, increased ease for parents
while participating in school activities with their child or community-based “mommy and me”
classes.
For the sertraline group, improvements in education were reported more frequently when
compared to the placebo. During one interview when discussing her daughter’s improvements in
the school setting, a mother named Lisa reported, “It does seem that she does pay attention if you
can sit down and teach her very basic things like ‘row, row, row your boat’. Very quickly she’ll
learn to anticipate those things… I’ve noticed a difference there.” This quote highlights how Lisa
was able to report positive education-related improvements and an increase in her daughter’s
ability sustain attention to learn new songs. The mother felt that this was improving her
daughter’s performance and participation in the classroom. When describing improvements in
participation during the school day and in the classroom, another parent, Toni, stated that her
daughter was participating more and that, “She actually talks in class.” Toni’s statement is an
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excellent example of a change that is very important for families with children who have FXS in
terms of success in the school or education-related occupations.
Positive family impacts. All of the interview transcripts were analyzed and coded to
determine the impact of FXS on family members of the children in the placebo and sertraline
groups. This overall impact, either positive or negative, was determined by coding for reports on
family members’ feelings about how their child’s behaviors impacted their daily lives. The
difference between the sertraline and placebo groups for overall family participation in the
community, and whether their experiences were positive or negative, was also analyzed. A
subcategory code under overall family impact was also created with descriptors related to
families’ perceptions of participating in the clinical medication trial as a whole. Overall, positive
impacts were reported more frequently by family members in the sertraline group. Additionally,
families in the sertraline group reported more of an ability to go out into the community and
participate in various social activities with their child, when compared to the placebo group. A
mother, Emma reported, “A couple weeks ago, we went out to dinner with our neighbors, and
took him to a place he has never been before, and through the whole entire dinner at a restaurant,
and was fine. He was completely fine. He sat and colored. So we can do more things like that.”
Going out to dinner as a family is an example of positive family impact. This family was able to
go out to dinner with their neighbors with limited negative family experiences. This is
substantial to occupational engagement, as often for families with FXS they avoid going to
dinner at all.
Perceptions of participating in the medication trial. Various descriptors for this code
category included reports such as, ease of medication administration, perceived positive social or
peer support during the study, sense of community, positive feelings about the choice to give the

30

LIVING WITH FXS: OCCUPATIONS AS OUTCOME MEASURE

child a medication. Family members in both the placebo and sertraline group reported positive
experiences related to participation in the clinical study. However, the frequency of reports
describing positive impacts of participation was higher among those in the sertraline group.
Some examples of positive experiences or perceptions of the study included reports of feeling
that participation was important and a way to contribute to the FXS community as a whole.
Several family members stated that regardless whether they were randomized to sertraline or
placebo, they were still happy they chose to enroll their child in the study due to the positives
outweighing any potential or actual negatives during the intervention period. One parent from the
placebo group, Linda, stated,
I hope that we will find something that really can make a difference in the lives of fragile
X patients and his family. For Johnny of course, I hope he keeps progressing and I am
really amazed with all of the support we have gotten. We are very pleased with that [and
we feel] very well taken care of...You know you enter in a trial like that and you are a bit
nervous, but the nervousness really went away right away...We would love to be
considered for future trials as well.
This parent captures a strong theme that many families reflected upon as they shared their
perception of the medical trial. Whether their child was on the sertraline or not, parents thought
that participating in the trail was beneficial for the FXS community.
Therapeutic Strategies
The second dominant theme that was found in the research was the use of therapeutic
strategies. Therapeutic strategies are approaches used to facilitate change in a person’s feelings,
thoughts or actions (Guidetti & Tham, 2002). Therapeutic strategies are often used in
occupational therapy to facilitate engagement in occupations. Interviews were coded for excerpts
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indicating use of different therapeutic strategies as methods of coping or managing various
behaviors and symptoms of FXS. Four categories of therapeutic strategies were coded due to the
frequency they were reported by parents in both the sertraline and placebo groups: behavioral
modifications, technology, communication supports in the form of visuals and the Picture
Exchange Communication System (PECS)® (Pyramidal Educational Consultants, n.d.) and
sensory strategies. For three of these code categories, parents in the sertraline group had a lower
frequency of reporting the need to use these strategies, with more parents reporting the need to
use them to manage unwanted behaviors or enhance functioning in the placebo group. However,
for sensory strategies, the sertraline group had higher frequency of reporting use of various tools
and activities to support sensory processing and self-regulation (See Figure 2).
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Figure 2 Therapeutic strategies were used by both the sertraline group and the placebo group. The placebo group
reported using behavioral modifications, technology, and communication support strategies more frequently
than the sertraline group. The sertraline group had a higher frequency of reporting use of sensory strategies.

Behavioral modifications. Behavioral modification strategies were used by both families
in the placebo and sertraline group. However, the frequency of behavioral modification strategies
reported were higher in the placebo group. Strategies for behavior modifications that families
used included positive reinforcement, a token reward system, stickers, and praise to encourage
positive behavior in the child. Gene, a grandmother of a child in the placebo group, shared a
therapeutic strategy, which she used when her grandson had a tantrum while grocery shopping,
“I just continued my shopping, the things I needed to do. I said, ‘well tell grandma what you
want to get, show me what you want to get’ things like this so he’ll pick out something and I’ll
get it for him. Try and get him a treat or something. By the time we’re done and we walked out,
he started to calm down, he was okay.” The grandmother used behavioral modifications, by
giving her grandson a treat, in order to complete her grocery shopping routine. This example
reflects how families have learned to use strategies to modify their child’s behaviors in order to
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participate in community activities.
Technology. Some examples of technology commonly used by families were iPhones,
iPads or computer games. In the placebo group parents reported a higher use of technology as a
proactive strategy. A parent from the placebo group described their use of technology during
daily routines and when out in the community with their child. Carla states,
We bring the iPad to the store too, so we can go do this and then get your iPad and play
with it after. He is starting to get a little bit of the cause and effect with that lately, a little
bit... We try to save it [iPad] for after or not at all because we want him to experience the
store and be able to sing songs or interact with us. So we try to not to use it. But we
definitely use it when we are in a restaurant. So any time we are in a restaurant there is no
chance, maybe 5 or 10 minutes. If there is a cart to sit in, he does really well, if it is
another situation and if he starts to get really anxious or upset, my husband will give him
his iPhone, we use something smaller to play with first. And it easier for us to take.
This is an example of how a family used technology in order for their family to participate in
community occupations.
Communication Supports. Parents from both the placebo and sertraline groups
described different therapeutic strategies aimed at supporting development of communication
skills and participation in the home and school environment. Some strategies referenced by
parents included the PECS® (Pyramidal Educational Consultants, n.d), visual supports including
communication boards and other augmentative communication systems. Mary, a mother of a
child in the placebo group described the benefits of using visuals as a strategy for her son, “His
teacher says, first this… then iPad. And he is used to the talking system.” This example
illustrates one of the ways families reported incorporating communication systems into daily
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routines to support their children when expressing needs and enhance the development of
communication skills during social interactions. When examining differences between the
groups, families in the placebo reported using communication supports more frequently than the
sertraline group.
Sensory strategies. Various sensory strategies were used by parents in both groups to
manage behaviors related to sensory functioning. Some examples of these strategies included
behavioral modifications, sensory strategies including weighted blankets and trampolines, use of
technology and communication devices, in order to help their child self-regulate more
effectively. For parents in the sertraline group, there were more reported frequency sensory
strategies used when compared to the placebo group. Dave, a parent of a child in the sertraline
group stated “We have a mini trampoline in our house and that at least give him something he
really likes to do… He jumps really high. He seeks it out when he needs it.” This family found
using a trampoline aided their child’s ability to self-regulate.
Discussion
The objective of the current research was to (1) examine if semi-structured parent
interviews can detect differences in improved daily function between placebo and treatment
groups when studying children with FXS in a clinical trial and (2) examine the difference in
behavioral outcomes between the two groups. Based on the results of the research, qualitative
analysis of semi-structured family interviews highlighted differences between the sertraline and
placebo groups. These findings show how interviews are important as an outcome measurement
because they capture valuable details of family life and occupational improvements. Qualitative
measures, like the interviews included in this study, provided families with the opportunity to
share their unique perspectives which in turn provided important and relevant information that
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can be used when determining the impact or changes in outcome measures among individuals
with FXS.
Effectiveness of Qualitative Interviews
Semi-structured interviews add context and relevant family experiences that are not
always captured by commonly used quantitative standardized assessments. Some examples of
this in the excerpts included above describe subtle improvements in areas such as receptive
communication or less unwanted behaviors that parents or family members noticed due to the
impact these changes have on their daily interactions and observations of the child with FXS.
However, these same improvements and positive changes may go undetected when using only
standardized or quantitative assessments. The need for alternative methods of outcome
measurement to improve sensitivity in outcomes was presented in previous research conducted
by Cohn, Miller and Tickle-Degnen (2000) in which researchers examined alternative methods
of outcome measurement in children with sensory modulation disorder. Through qualitative
analysis of parent interviews results indicated several child-focused and parent-focused outcomes
that were effective in determining sensory processing difficulties (Cohn et al., 2000). These
results are similar to the current study, which found that semi-structured parent interviews
allowed for analysis and identification of important themes related to the family experience and
daily functioning of children with FXS.
In quantitative studies, the research team cannot always directly observe the participants
as they complete daily functional activities. Additionally, standardized assessments do not
always capture improvements or changes that actually are occurring. To address this gap in
outcome measurement, accounts from families provide important information based on the
parents’ understanding of how their children respond to a medication, such as sertraline, as an
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intervention. Thus, the use of qualitative measures can be very valuable in a medication trial for
children with FXS, especially when assessing information regarding occupational performance
and important areas of daily functioning.
Differences in Outcomes
Improvements in daily functioning. Through qualitative analysis of parental interviews,
which involved coding transcribed responses from parents, several important similarities and
differences in daily functioning were found between groups when compared to research
completed by Hess et al. (2016). The current qualitative study was consistent with findings from
Hess et al. (2016) in regards to social participation and receptive language. Hess et al. (2016)
found that children in the sertraline group made statistically significant improvements in social
participation using the SPM-P. This was consistent to the results found during the current study’s
qualitative analysis. Additionally, qualitative analysis of the results in the current study found
improvements in receptive language in children in the sertraline group. This was also consistent
with findings by Hess et al. (2016), which found statistically significant improvements in
receptive language of children in the sertraline group using the MSEL assessment. Both
quantitative outcome measures and qualitative analysis of occupations yielded consistent results
in terms social participation and receptive language of children in the sertraline group. The
consistency of results shows how qualitative methods are an effective measure for capturing
occupational improvements in clinical trials. Furthermore, this qualitative study was also
consistent with Hahn and colleagues (2013) who found that receptive language commonly
develops quicker than expressive language with children with FXS. Through the use of this
qualitative research, parents indicated more improvements in receptive language in the sertraline
group. Improvements in expressive language were not found to be different between the two
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groups, which was consistent with findings of Hahn et al. (2013).
Qualitative analysis of the data demonstrated trends of improvement in several areas
which were not apparent in results from quantitative assessment measures used by Hess and
colleagues in the clinical sertraline trial (2016). These areas illuminated in the current study
included trends of improvements in behavioral, sensory and educational code categories that
were reported among children in the sertraline group through qualitative analysis. The semistructured interviews analyzed in the current study were sensitive outcome measure to capture
improvements in these areas of daily functioning, which add to the findings based on quantitative
outcome measures in Hess et al. (2016). The semi-structured parent interviews as an outcome
measure was more sensitive to the FXS population in these categories.
The results of this research supports the inclusion sociocultural theory in a clinical
medication trial. According to Vygotsky (1930), a child’s cognitive development and learning is
dependent on his or her social interactions. The child’s environmental interactions, including
physical and social, are crucial to their development of behaviors. The use of sertraline in
children with FXS improved behaviors and social participation to allow increased interactions in
their environment to further improve their development.
This qualitative research adds to the growing body of research on the benefits of
medication on occupational performance. Reilly and colleagues (2015) described families of
children with FXS often reported feeling restricted in their ability to engage in family activities
outside of the home. This research through the use of qualitative measures revealed that children
on sertraline improved in their ability to participate socially in the community. Through the
process of semi-structured interviews, many families reported they were able to take their child
out to grocery stores, to restaurants and to social gatherings. Sertraline was beneficial in
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improving children with FXS ability to socially participate in their communities as well as with
peers, adults and family members.
Therapeutic strategies. Results from the current study also uncovered specific
therapeutic strategies used by families in both the sertraline and placebo groups. This
information is meaningful due to the importance of these strategies for parents or families when
managing unwanted behaviors to carry out daily routines and occupations for their children with
FXS. The results indicated less reporting of the overall strategies used by the sertraline group,
with the exception of sensory strategies. This finding may indicate that families in the sertraline
group did not need to use as many strategies because of improved behaviors across the board. In
contrast, however we found sensory strategies were reported more frequently in the sertraline
group. This may have been the result of positive responsiveness to the specific sensory strategy
for children taking sertraline. More research is needed in this area to assess children taking
sertraline and their responses to sensory strategies.
Rigor
The rigor of this research was enhanced with the use of three code descriptors improved,
not improved and no change. By adding the descriptor, no change, our codes were very
conservative denoting any change. This code indicated that parents reported there was no
difference in the child in any of the following categories, anxiety, behavior, communication,
education, functional/ADL, sensory, sleep, play and social participation. The inclusion of the no
change code increased the rigor as excerpts were coded more conservatively than just two
categories alone, improved and not improved.
Implications for OT Practice
Results from this study show the benefits of using qualitative methods in clinical
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medication trials as it allows for a richer understanding of the lives of families with children with
FXS. Inclusion of parental interviews in clinical medication trials can add valuable information
that is not reflected thorough surveys and standardized assessments alone.
Occupational therapists can use this research to better understand the effects of
medication on children with FXS. Research results suggest that the medication, sertraline,
enhances the child’s ability to perform specific occupations. Furthermore, this research reflects
the benefits of including occupational therapists when conducting clinical medication trials as
occupational therapists are trained to evaluate children’s daily occupational functioning
It is possible that sertraline places the child at an optimal zone of proximal development,
which allows the child to be open to receive skilled intervention and perform specific
occupations. If the child is placed in a more optimal zone with the help of the outside
reinforcement of medication, the child may have more skill development. Social environments
and culture are important factors for learning and must be considered when conducting
contextually-based interventions for both children with FXS and their families. When used in
conjunction with contextual factors, medication can be a helpful tool to manage behaviors and
may support learning and improve occupational performance. Outcome measures in clinical
trials inclusive of socio-cultural and occupational factors may gather a broader scope of daily life
improvements versus what can be measured on quantitative instruments (e.g. mostly
performance skills) alone.
Future Directions, Limitations and Conclusion
Future Directions
Future medication trials should incorporate qualitative semi-structured interviews to
broaden the data collected to understand how medication affects the participants’ engagement in
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daily occupations. Future research studies can also perform member checks to confirm the
accuracy of the parent responses during the interview process. Additionally, researchers can
contact former participants in the research study to further assess participants current
occupational functioning. Lastly, the researchers can assess if the individuals and families chose
to stay on the sertraline and how their child's occupations have changed since being in the
medication trial.
Limitations
This study was a continuation of the research completed by Hess and colleagues in 2016.
The limitations faced in the study by Hess et al. (2016) were also potential limitations in this
present study. Since FXS affects more males than females, there was an unbalanced boy to girl
ratio of participants in the original study. Having an unbalanced ratio could possibly make it
more difficult to understand the effects of sertraline between boy and girl subjects. Furthermore,
girls often experience milder symptoms of FXS than boys (Brady et al., 2006). This could
potentially skew the data because girls with FXS are often higher functioning than boys with
FXS.
Another limitation in this study was the use of a small sample size, which consisted of 25
participants. The small sample size may cause skewed results. Furthermore, one parent was not
blind when the interview took place due to scheduling conflicts. This parent knew whether his
child received sertraline or the placebo. This interview is considered an outlier because the
responses may have been biased.
A final limitation was that the researchers were unable to complete a member check as
the previous study was already complete. Completing a member check would entail a follow up
with the families to confirm the accuracy of the responses that were given during the original
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study.
Conclusion
FXS is the leading cause of inherited intellectual disability, and manifests in significant
cognitive deficits, sensory, behavioral, and emotional dysregulation (Hess et al., 2016).
Sertraline has been used clinically to treat symptoms related to FXS (Hess et al., 2016). Because
of the complexity of FXS, standardized assessments are not a comprehensive measure to detect
all changes in daily occupational functioning (Hall et al., 2012). The purpose of the study was to
assess additional outcome measures that would potentially be more sensitive in detecting daily
functional changes in this population. This qualitative study was carried out through a secondary
analysis of semi-structured parent interviews selected from a sertraline and placebo group
included in a clinical medication trial conducted at the UC Davis MIND Institute (Hess et al.,
2016). The results of this study indicated differences related to improvements in daily
functioning and also highlighted important information related to the use of therapeutic strategies
among families to improve and cope with unwanted behaviors in children with FXS.
Semi-structured interviews provide meaningful information on occupational performance
through analysis of the daily lived experiences among families with FXS. The results of this
study also support the relevance of including qualitative measures that can capture subtle
changes or improvements in a child with FXS that occur through the interaction of social and
contextual factors found in the family environment. The current research study expanded on
previous quantitative studies by enhancing the sensitivity of outcome measurement and
decreasing the likelihood of overlooking significant positive changes in behavior and
occupational functioning.
The use of semi-structured parent interviews allowed for a more comprehensive way to
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capture family’s experiences through an occupation-centered lens. This qualitative research
detected improvements in children with FXS that were not detected in quantitative measures due
to floor effects and small effect sizes. When used in conjunction with contextual factors,
medication can be a useful tool to manage behaviors, support learning and improve occupational
performance. Occupational therapists can use this research to better understand the effects of
medication on children with FXS. Research results suggest that the sertraline medication
enhances the child’s ability to perform specific occupations.
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Confidentiality Agreement for Human Subject Research Assistants
Human subject research includes confidential and personal matters, some of which may involve
a subject’s rights of privacy protected by law, attorney-client privileged communications, and
proprietary information. I agree to maintain confidentiality with respect to any private or
personal information that I become aware of, or have access to, during the course of my activity
as a research assistant. In providing support to the research project, I am considered a
“confidential employee.” I am prohibited from releasing information to or discussing information
with anyone not employed in this specific research project, except as I am directed by the
primary investigator or as is necessary in the ordinary course of performing my duties in the
research activity.
I agree to maintain confidentiality of these matters while I am working on the research project
and following the completion of my work association on this activity.
At all times during my participation, I shall promptly advise the primary investigator of any
knowledge that I may have of any unauthorized release or use of confidential or personal
information, and shall take reasonable measures to prevent unauthorized persons from having
access to, obtaining, or being furnished with any such information.
Print Name: _______________________________________________
Signature:

_____________________________ Date: ____________________
The policies were explained to me by:

_______________________________
Name

______________________________
Title
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Letter of Approval
Permission from Principal Investigator for access to FXS Database - U.C. Davis MIND
Institute
Hi Randi
I have 2 capstone research groups who will be working on transcribing and analyzing the FXS
family interviews that were part of the Sertraline research project. My students have
enthusiastically set about their lit reviews and are generating exciting proposals. We are now to
the IRB drafting phase here at Dominican.
Would you via response to this email provide us with permission as the PI to access this data?
We can then include this as documentation as part of our IRB here.
It has been very rewarding and exciting to teach my students about FXS and have them embark
on their research in this area as they become occupational therapists.
Hope this finds you happy and well
take care
Laura
Laura Greiss Hess, PhD, OTR/L
(laura.hess@dominican.edu)
Assistant Professor
Department of Occupational Therapy
Dominican University of California
50 Acacia Ave.
San Rafael, CA 94901
415-482-1906
Hi Laura, This sounds great and yes you have my permission to do this. I hope all is going well
for you. Take care,Randi
Randi J. Hagerman, M.D.
Medical Director of the MIND Institute
Distinguished Professor
Endowed Chair in Fragile X Research
UC Davis Health System
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Parental Interview Questions
During our first interview we were able to discuss your child’s strengths and patterns including
behavior, sensory, anxiety and communication and the impact on your family. As a follow up to
that conversation, today I would like us to discuss any changes you have seen since beginning
the study in these areas and the impact to your family.
1. Let’s start with activity level and behavior. What changes if any have you noticed and
how has that impacted you as a family.
2. Have you noticed any changes related to anxiety? How has that impacted you as a
family?
3. Have you noticed any changes related to sensory processing? How has that impacted you
as a family?
4. Have you noticed any changes related to communication? How has that impacted you as
a family?
5. Do you think you were given the placebo or the medication? What were you observing /
feeling that has led you to wonder whether you had the medication or not?
6. Is there anything you would like to share in terms of your family’s involvement in the
research study regarding what you have learned thus far and what your hopes are for
learning that can come out of the research?
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Codes and Operational Definitions
Code

Operational Definition

Anxiety improved

Parent stated that the child's anxiety got better. Less
anxious in ___. Ex. crowded places, new environments,
school etc.

Anxiety no change

Parents stated that the level of anxiety or behaviors
related to anxiety have remained the same (child is still
doing it). Ex.Pacing, Flapping, getting upset etc.

Anxiety worsened

Parents stated an increase in anxiety related behaviors.
This includes an increase in frequency or intensity or
new anxiety behaviors.

Behavior improved

Parent code. Parents report general statement of
improvement, more adaptive and positive behaviors, and
less maladaptive behaviors. Ex. positive behaviors,
improved attention, improved compliance, and
statements like "just acting better."

Behavior more (positive)

Parents report more positive behaviors, more
compliance, more attention, or more focus.

Behavior more (negative)

Parents report less hitting, tantrums, biting, etc. Less
unwanted behaviors or less maladaptive behaviors.

Behavior no change

Parent states that behavior has remained the same. This
includes examples of stories that don't include any
different behaviors. They state what the child does and
doesn’t say that it has changed.

Behavior worsened

Parent states that the child has gotten worse. Ex. more
hitting more biting, more tantrums etc.

Communication improved

Parent code. General statements from parents. It can be
verbal or nonverbal. Ex. "their language is better"

Expressive language improved

Parents report more talking. The child is expressing
wants and needs. Does not have to be words, can be non
verbal. Ex. holds your hands and brings you to what he
wants, more signs, sounds or words spoken.
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Receptive language improved

Parents report more understanding of verbal and
nonverbal communications.

Communication no change

Parents stated that there is no difference in overall
communication. (receptive and expressive)

Expressive language no change

No stated difference in overall expressive
communication

Receptive language no change

No stated difference in overall receptive communication

Communication worsened

Parents report a decline in overall communication. Ex.
language is just worse.

Expressive language worsened

Parents report a decline in expressive communication.
Ex. Less words spoken, less signs etc.

Receptive language worsened

Parents report a decline in receptive communication.
Ex. Less understanding of parent, caregiver etc.

Education worsened

Parents reported less participation, less active in school
activities. Can be reported by teacher. This includes
Kindergarten, Preschool, Daycare, Classes with parent
or extracurricular classes ("Mommy and me" classes,
library music classes, community art class).

Education improved

Parents reported more participation, more active in
school activities. Can be reported by teacher. This
includes Kindergarten, Preschool, Daycare, Classes with
parent or extracurricular classes ("Mommy and me"
classes, library music classes, community art class).

Education no change

Parents reported no change in participation, no change
in activity levels in school activities. Can be reported by
teacher. This includes Kindergarten, Preschool,
Daycare, Classes with parent or extracurricular classes
("Mommy and me" classes, library music classes,
community art class).

Family impact not positive

Parents report a negative outlook on situation and are
impacted negatively from FXS. Ex. More secluded

Perception of participation in Study

Parents report a negative impacts as a result of
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-Neg

participating in the study

Family impact positive

Parents report a positive outlook on situation. Ex. Less
secluded

Perception of participating in studypositive

Parents have a positive outlook on participation in the
study. Parents feel that the participation in the study was
important to research, selves, community etc.

Family impact no change

Family reports no change in situations and no less/more
secluded.

Functional/ADL worsened

Parent states that behaviors worsened related to ADLs,
safety, daily tasks etc.

Sleep worsened

Parents state worse sleep habits, going to bed more
difficult, or staying asleep more difficult.

Functional/ADL improved

Parents report participation in ADLs, dressing, bathing,
responding to day to day tasks / activities in the house
participation in routines, safety has improved. Ex. go get
your shoes, go get your iPad

Sleep improved

Parents report better sleep habits, going to bed easier or
staying asleep better.

Functional/ADL no change

Parents report no changes in behaviors related to ADL,
safety, participation in daily activities and tasks etc.

Sleep no change

Parents report no change in sleep habits

Play worsened

Parents report child is using less toys and equipment,
participating in less play etc.

Play improved

Parents report child is using more toys and equipment
Types of Play: practice play, pretend play, participating
in more play, playing with someone else-double code
play and social participation

Play no change

Parent stated that there was no improvement or change
in play participation.

Sensory worsened

Parent report general worsening of sensory. Ex. Put
more things in mouth, bite more objects etc.
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Sensory improved

Parents report general improvements in sensory.

Sensory improve (Less sensory
behaviors)

Parents report less harmful or disruptive reactions to
sensory stimuli or sensory experiences
(crowded/changing environments, different textures,
sounds.) Ex.Less maladaptive behaviors, less stimming,
Less rocking or hitting (self or others) in reaction to
sensory stimuli etc.

Sensory improve (more)

Parents report more positive or adaptive reactions to
sensory stimuli, longer duration of tolerance for
different sensory experiences, increase in tolerance for
different sensory experiences/stimuli, more exploration,
more participation in sensory related etc.

Sensory no change

Parent/caregiver does not describe or state any changes
in sensory. Child still using same behaviors or reacting
in the same way to sensory experiences, in a positive or
negative way.

Social participation worsened

Parents report decreased engagement in community,
family, peer or friends. Engaging in activities that result
in negative interactions at community level. Ex. going to
the park, going to the museum, going out to dinner etc.

Social participation improved

Parents report improved engagement in community,
family, peer or friends. Engaging in activities that result
in positive interactions at community level. Ex. going to
the park, going to the museum, going out to dinner etc.

Social participation no change

Parent states no different in level or quality of
involvement in community or participation in social
environments/activities.

Strategies

Proactive strategies that parents do to help their child
cope, calm or self regulate. Ex. watching favorite tv
show, blankie

Behavioral modifications

Use or earning of tokens, edibles, points, stickers, praise
etc.
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Communication/ PECS

Communication board, PECS, adaptive equipment for
communication

Sensory strategies

Strategies to help dysregulation Ex. blanket, deep
pressure etc.

Technology

Use of iPad, iPhone, computer or other form of
technology as a calming strategy or behavioral strategy.
Ex. watching music videos on YouTube, playing a
favorite game on the iPad etc.

Visual supports

Visual schedule, labeling room / classroom

Questions

Code when you have a question

Quotes

Meaningful quotes that parents say during interview
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